Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/springer-journals/the-tumor-spectrum-in-the-lynch-syndrome-1eB80GeHaY
References (19)
-
J. Wijnen, Wiljo Leeuw, H. Vasen, H. Klift, P. Møller, A. Stormorken, H. Meijers-Heijboer, D. Lindhout, F. Menko, S. Vossen, G. Möslein, C. Tops, A. Bröcker-Vriends, Ying Wu, R. Hofstra, R. Sijmons, C. Cornelisse, H. Morreau, R. Fodde (1999)
Familial endometrial cancer in female carriers of MSH6 germline mutationsNature Genetics, 23
-
H. Vasen, J. Wijnen, F. Menko, J. Kleibeuker, B. Taal, G. Griffioen, F. Nagengast, E. Meijers-Heijboer, L. Bertario, L. Varesco, M. Bisgaard, J. Mohr, R. Fodde, Khan Pm (1996)
Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.Gastroenterology, 110 4
-
Fáblio Ferreira, C. Ferreira, B. Rossi, Wilson Nakagawa, Samuel Aguilar, Erika Santos, Marcelo Costa, A. Lopes (2004)
Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional RegistryFamilial Cancer, 3
-
H. Vasen, H. Morreau, J. Nortier (2001)
Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer?American journal of human genetics, 68 6
-
Rodney Scott, Rodney Scott, M. McPhillips, C. Meldrum, P. Fitzgerald, Kirsten Adams, A. Spigelman, D. Sart, K. Tucker, J. Kirk (2001)
Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds.American journal of human genetics, 68 1
-
M. Bakker, C. Seynaeve, M. Kliffen, W. Dinjens (2003)
Microsatellite instability in a pleomorphic rhabdomyosarcoma in a patient with hereditary non‐polyposis colorectal cancerHistopathology, 43
-
J. Risinger, J. Barrett, P. Watson, H. Lynch, J. Boyd (1996)
Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndromeCancer, 77
-
J. Boyd, E. Rhei, M. Federici, P. Borgen, P. Watson, B. Franklin, Beth Karr, J. Lynch, S. Lemon, H. Lynch (2004)
Male breast cancer in the hereditary nonpolyposis colorectal cancer syndromeBreast Cancer Research and Treatment, 53
-
M. Gail, D. Pee, J. Benichou, Ray Carroll (1999)
Designing studies to estimate the penetrance of an identified autosomal dominant mutation: Cohort, case‐control, and genotyped‐proband designsGenetic Epidemiology, 16
-
A. Müller, T. Edmonston, Diana Corao, D. Rose, J. Palazzo, H. Becker, R. Fry, J. Rueschoff, R. Fishel (2002)
Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer.Cancer research, 62 4
-
HT Lynch, A. Chapelle (2003)
Genomic medicine: Hereditary colorectal cancerN Engl J Med, 348
-
M. Dunlop, M. Dunlop, S. Farrington, S. Farrington, A. Carothers, A. Wyllie, L. Sharp, J. Burn, Bo Liu, K. Kinzler, B. Vogelstein, B. Vogelstein (1997)
Cancer risk associated with germline DNA mismatch repair gene mutations.Human molecular genetics, 6 1
-
S. Cai, Ye Xu, G. Cai, P. Lian, Z. Guan, S. Mo, Menghong Sun, Q. Cai, D. Shi (2003)
Clinical characteristics and diagnosis of patients with hereditary nonpolyposis colorectal cancer.World journal of gastroenterology, 9 2
-
Young-Jin Park, K. Shin, J. Park (2000)
Risk of gastric cancer in hereditary nonpolyposis colorectal cancer in Korea.Clinical cancer research : an official journal of the American Association for Cancer Research, 6 8
-
P. Watson, H. Lynch (2004)
Cancer risk in mismatch repair gene mutation carriersFamilial Cancer, 1
-
Anne Jiger, M. Bisgaard, Torben Myrh, I. Bernstein, J. Rehfeld, F. Nielsen (1997)
Reduced frequency of extracolonic cancers in hereditary nonpolyposis colorectal cancer families with monoallelic hMLH1 expression.American journal of human genetics, 61 1
-
H. Lynch, A. Chapelle (2003)
Hereditary colorectal cancer.The New England journal of medicine, 348 10
-
Y. Parc, C. Boisson, G. Thomas, S. Olschwang (2003)
Cancer risk in 348 French MSH2 or MLH1 gene carriersJournal of Medical Genetics, 40
-
M. Aarnio, R. Sankila, E. Pukkala, R. Salovaara, L. Aaltonen, A. Chapelle, P. Peltomäki, J. Mecklin, H. Järvinen (1999)
Cancer risk in mutation carriers of DNA‐mismatch‐repair genesInternational Journal of Cancer, 81
- Publisher
- Springer Journals
- Copyright
- Copyright © 2005 by Springer
- Subject
- Medicine & Public Health; Human Genetics; Oncology; Epidemiology
- ISSN
- 1389-9600
- eISSN
- 1573-7292
- DOI
- 10.1007/s10689-004-7994-z
- pmid
- 16136385
- Publisher site
- See Article on Publisher Site
Abstract
Colorectal and endometrial cancer are the characteristic tumors of the Lynch syndrome. We reviewed the available evidence on the occurrence of other types of cancer in the syndrome, aiming to identify those types that can be included in the tumor spectrum, based on this evidence. We chose to define the tumor spectrum as comprising the cancers for which Lynch syndrome patients are at elevated risk. We found sufficiently strong and consistent evidence to include gastric cancer, small bowel cancer, hepatobiliary tract cancer, upper urologic tract cancer, ovarian cancer, and brain tumors in this spectrum, in addition to colorectal and endometrial cancer. We predict that the spectrum will expand as additional studies are reported, especially as prospective studies of mutation carriers are completed.
Journal
Familial Cancer – Springer Journals
Published: Dec 21, 2004